Windward Bio Group AG (WWB) P/E Ratio, ROE & Key Statistics
$31.00NASDAQ: WWBMarket Cap $478.67M
Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Windward Bio Group AG (WWB), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/B ratioShare price divided by book value per share.
1.67
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-20.09
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
0.00%
Operating marginRevenue left after operating costs.
0.00%
Net marginRevenue left after every cost, including tax and interest.
0.00%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
8.57
Quick ratioThe same, excluding inventory.
8.49
Debt to equityTotal borrowings against shareholders’ equity.
0.00
Per share and size
Metric
Value
Market capitalisationShare price times shares outstanding.
$478.67M
Windward Bio Group AG (WWB) statistics — frequently asked questions
How much debt does Windward Bio Group AG carry?
Windward Bio Group AG (WWB) has a debt-to-equity ratio of 0.00, which compares total borrowings with shareholders' equity.
P/E and ROE of other Medical - Pharmaceuticals stocks